Kestra Advisory Services, LLC Novavax Inc Transaction History

Kestra Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $324,560 - $673,544	-8,946 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$69.73 - $142.9 $319,712 - $655,196	-4,585 Reduced 33.89%	8,946 $658,000
Q4 2021 Jan 20, 2022	BUY	$134.56 - $217.97 $88,540 - $143,424	658 Added 5.11%	13,531 $1.94 Million
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $581,939 - $885,608	3,273 Added 34.09%	12,873 $2.67 Million
Q2 2021 Jul 28, 2021	BUY	$121.0 - $257.67 $705,551 - $1.5 Million	5,831 Added 154.71%	9,600 $2.04 Million
Q1 2021 May 10, 2021	BUY	$112.98 - $319.93 $85,864 - $243,146	760 Added 25.26%	3,769 $683,000
Q4 2020 Jan 20, 2021	BUY	$78.74 - $139.5 $236,928 - $419,755	3,009 New	3,009 $358 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.